Pain Severity in Flapless Dental Implant Placement Using Laser

The Evaluation of Pain Severity in Flapless Dental Implant Placement Using Laser-induced Incisions: A Split Mouth Randomized Clinical Trial Study

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06294249

Enrollment

Registered

2024-03-05

Start date

2020-01-01

Completion date

2023-12-04

Last updated

2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaw, Edentulous, Partially

Keywords

Jaw, Edentulous, Partially, Pain Measurement, Laser Therapy, Dental Implants, Randomized Controlled Trial

Brief summary

The goal of this split-mouth randomized clinical trial study was to investigate the effect of using a laser on pain and discomfort following flapless dental implant surgery. It was hypothesized that laser did not have any impact on post-op pain. Therefore, the study aimed to compare pain and discomfort following flapless dental implant surgeries with or without a laser.

Interventions

DEVICELaser-induced Incision

On the treatment side, an incision was made on the crest of the alveolar soft tissue using the laser.

PROCEDUREPunch Incision

On the control side, a punch incision was made on the crest of the alveolar soft tissue using using a punch.

PROCEDUREImplant Placement

Implant placement was done in both laser and punch arms. The drilling was performed based on the company (Straumman) protocol. On each side, a dental implant (Straumman SP, Basel, Switzerland) and healing abutment were placed. Patients were visited at 24, 48, 72 hours, and 7 days after insertion.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Adult human subjects agreed to participate in the study and return on follow-up times 2. Subjects eligible for receiving dental implants 3. Subjects with an edentulous area in the posterior of the mandible bilaterally 3- Subjects with sufficient bone width and height (\>5 mm width, and \>10 mm height) at the implant sites 4. Subjects with sufficient keratinization tissue at the implant sites

Exclusion criteria

1. Subjects refused to return for follow-up or refused study enrollment. 2. Subjects with uncontrolled systemic diseases 3. Subjects younger than 18 years 4. Subjects receiving psychotropic drugs

Design outcomes

Primary

Measure	Time frame	Description
Pain Severity	Patients were visited at 24, 48, 72 hours, and 7 days after insertion.	Measured using the visual analogue scale (VAS): 0-3 mild pain, 4-6 moderate pain, and 7-10 sever pain.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026